An Open Letter to the BioPharma Community
We the undersigned support guiding principles and best practices to increase gender diversity.
An Open Letter to the BioPharma Community:
Now that it’s 2017, we are choosing to write this letter to provide recommendations for best practices to establish gender diversity as a priority for the biopharma industry.
Last year’s open letter to the industry sparked a dialogue that led to changes in some company practices, new training programs, regional gender diversity initiatives and much more.